Increased risk of wasting syndrome in HIV-infected travellers: prospective multicentre study

被引:11
|
作者
Furrer, H
Chan, P
Weber, R
Egger, M
机构
[1] Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England
[2] Univ Spital Bern, Ambulatorium Infekt Krankheiten, Bern, Switzerland
[3] Univ Spital Zurich, Abt Infekt Krankheiten & Spitalhyg, Zurich, Switzerland
关键词
HIV infections; travellers; disease progression; opportunistic infections; wasting syndrome; tropics;
D O I
10.1016/S0035-9203(01)90011-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
HIV-infected patients from moderate regions who travel in tropical countries may experience clinical disease progression due to exposure to bacteria (including mycobacteria), fungi and parasites. In the Swiss HIV Cohort Study we examined the hypothesis that travelling increases the risk of tuberculosis, wasting syndrome, cryptosporidiosis, isosporiasis, cryptococcosis, coccidiomycosis, histoplasmosis and Salmonella septicaemia. A total of 4549 participants were included (in 1988-98) of whom 596 (13.1 %) travelled at least once. During 16 800 person-years of follow-up 231 patients developed at least 1 of the diseases of interest. Wasting syndrome was the only diagnosis significantly associated with travelling (hazard ratio 2.16, 95% confidence interval 1.09 to 4.30). The risk of wasting syndrome ('slim disease') should be taken into account when counselling HIV-infected patients intending to travel in tropical regions.
引用
收藏
页码:484 / 486
页数:3
相关论文
共 50 条
  • [1] Wasting syndrome in HIV-infected patients
    Emerole, K. C. H.
    Pokrovskaya, A. V.
    Pilipenko, V. I.
    [J]. TERAPEVTICHESKII ARKHIV, 2016, 88 (05): : 125 - 129
  • [2] Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome - a population pharmacokinetic study
    Mouly, S
    Aymard, G
    Tillement, JP
    Caulin, C
    Bergmann, JF
    Urien, S
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (06) : 557 - 565
  • [3] Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study
    Antonucci, G
    Girardi, E
    Raviglione, M
    Vanacore, P
    Angarano, G
    Chirianni, A
    Pagano, G
    Suter, F
    Lauria, FN
    Ippolito, G
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) : 369 - 375
  • [4] Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome
    Gatti, G
    Di Biagio, A
    De Pascalis, CR
    Guerra, M
    Bassetti, M
    Bassetti, D
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (05) : 704 - 711
  • [5] Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome
    Guzman-Fulgencio, Maria
    Micheloud, Dariela
    Lorente, Raquel
    Maria Bellon, Jose
    de Jose Gomez, Maria Isabel
    Dolores Gurbindo, Maria
    Antonio Leon, Juan
    Angeles Munoz-Fernandez, Maria
    Resino, Salvador
    [J]. JOURNAL OF INFECTION, 2011, 62 (03) : 240 - 243
  • [6] ORAL SUPPLEMENTS IN HIV-INFECTED PATIENTS WITH CHRONIC WASTING - A PROSPECTIVE TRIAL
    BURGER, B
    SCHWENK, A
    JUNGER, H
    OLLENSCHLAGER, G
    WESSEL, D
    DIEHL, V
    SCHRAPPE, M
    [J]. MEDIZINISCHE KLINIK, 1994, 89 (11) : 579 - 581
  • [7] Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia:: prospective multicentre study
    Furrer, H
    Opravil, M
    Rossi, M
    Bernasconi, E
    Telenti, A
    Bucher, H
    Schiffer, V
    Boggian, K
    Rickenbach, M
    Flepp, M
    Egger, M
    [J]. AIDS, 2001, 15 (04) : 501 - 507
  • [8] Cardiovascular risk estimation in Spanish HIV-infected patients: a multicentre cohort study
    Ferrer, E.
    Minguez, C.
    Marino, A.
    Geijo, P.
    Brun, F.
    Sanz, J.
    Velasco, M.
    Cortes, C.
    Castro, A.
    Orti, A.
    Force, Ll
    Barrufet, P.
    Villalonga, C.
    Podzamczer, D.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (08) : A74 - A75
  • [9] Pregnancies in HIV-infected adolescents: a multicentre descriptive study
    Elgalib, A.
    Samarawickrama, A.
    Roedling, S.
    Tariq, S.
    Draeger, E.
    Hegazi, A.
    Rathnayaka, T.
    Azwa, A.
    Hawkins, D.
    Rodgers, M.
    Shah, R.
    Edwards, S.
    Russell, J.
    Noble, H.
    Poulton, M.
    Anderson, J.
    Taylor, G.
    de Ruiter, A.
    [J]. HIV MEDICINE, 2009, 10 : 4 - 4
  • [10] A PROSPECTIVE-STUDY OF THE RISK OF TUBERCULOSIS AMONG HIV-INFECTED PATIENTS
    GUELAR, A
    GATELL, JM
    VERDEJO, J
    PODZAMCZER, D
    LOZANO, L
    AZNAR, E
    MIRO, JM
    MALLOLAS, J
    ZAMORA, L
    GONZALEZ, J
    SORIANO, E
    [J]. AIDS, 1993, 7 (10) : 1345 - 1349